Clinical trial
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron…
NCT02940860 · Pharmacosmos A/S, Industry · Completed
Key facts
| NCT number | NCT02940860 |
|---|---|
| Title | Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease |
| Official title | A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) and Iron Sucrose in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (FERWON-NEPHRO) |
| Lead sponsor | Pharmacosmos A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Iron isomaltoside/ferric derisomaltose, Iron sucrose |
| Enrollment | 1,538 |
| Start date | Nov 29, 2016 |
| Primary completion | May 29, 2018 |
| Completion | May 29, 2018 |
| First posted | Oct 21, 2016 |
| Last update posted | Oct 6, 2020 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: